Overcoming time pressure and the global shortage of test kits and reagents, the 8-member Microbiology team from Gleneagles Hospital Hong Kong’s Clinical Laboratory has made in-house COVID-19 testing a reality, about two months after Hong Kong confirmed its first COVID-19 case.
Today, Gleneagles Hospital Hong Kong is capable of testing up to 150 COVID-19 samples daily in its laboratory. It uses two test platforms (POCT or point of care testing and PCR or polymerase chain reaction testing), to provide quality and efficient service to meet our patients’ needs.
Between end of March and end of May, the hospital tested more than 200 cases, while supporting the Hong Kong Government Department of Health’s Community Deep Throat Saliva Surveillance Programme with about 300 cases.
The team is ramping up the laboratory’s testing capacity to meet the anticipated surge in testing demand as the government prepares to open up its borders to businesses travellers with negative COVID-19 nucleic acid testing result certification.
By making COVID-19 testing available to our patients and the medical needs of our clinicians, Gleneagles Hospital Hong Kong is helping to stem the spread of the virus in the community. It is also keeping our hospital safe for our inpatients and frontline staff, ensuring that it continues to provide uninterrupted healthcare services during the COVID-19 pandemic.
Related Stories
IHH Healthcare Strengthens India Presence with Integrated Platform and Innovation Push
IHH Healthcare is accelerating its expansion in India, as rising healthcare demand drives the Group to scale its operations through integration, capacity growth and innovation-led initiatives.
IHH Healthcare calls for urgent shift from climate awareness to action at Sustainability Week Asia
At the 6th annual Economist Impact Sustainability Week Asia, IHH Healthcare’s Group Chief Sustainability Officer Yasemin Tecmen Stubbe underscored the growing urgency for organisations to embed climate resilience into day-to-day operations, rather than treating it as a future concern.
Parkway Shanghai Hospital Inaugurates Pan Vascular Centre
The new multidisciplinary hub integrates six specialties to deliver full-cycle care for vascular diseases, reinforcing healthcare innovation in China.
Gleneagles Hospital Hong Kong Participates in Fourth Red Cross City Challenge
Driven by IHH’s aspiration to “Care. For Good.”, Gleneagles Hospital Hong Kong continues its commitment to empower communities by continuously supporting humanitarian causes.
Fortis Healthcare Hosts 1st Annual Neuro-conclave Mumbai 2026
Fortis Healthcare marked the successful conclusion of the 1st Annual Neuro-conclave Mumbai 2026, held on 21 and 22 March, showcasing the strength and integration of its neuroscience team.
IHH Malaysia Supports 10KM Category at Penang Bridge International Marathon
IHH Malaysia is the 10KM title sponsor for the upcoming Penang Bridge International Marathon 2026 (PBIM), encouraging individuals of all fitness levels to embrace a more active lifestyle.
